| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA990000951900403321 |
|
|
Autore |
Ahlfors, Lars Valerian |
|
|
Titolo |
Complex analysis : An Introduction to the Theory of Analytic Functions of One Complex Variable / Lars V. Ahlfors |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
New York [etc.] : McGraw-Hill, 1966 |
|
|
|
|
|
|
|
Edizione |
[2nd ed.] |
|
|
|
|
|
Descrizione fisica |
|
|
|
|
|
|
Collana |
|
International series in pure and applied mathematics |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Locazione |
|
|
|
|
|
|
Collocazione |
|
S.16-023 |
S.16-002 |
S.16-022 |
S.16-001 |
S.16-021 |
16-002.002 |
S.16-004 |
S.16-003 |
S.16-020 |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
|
|
|
|
|
|
|
2. |
Record Nr. |
UNINA9910959531903321 |
|
|
Autore |
Maratos Jason <1943-> |
|
|
Titolo |
Foundations of group analysis for the twenty-first century: foundations / / by Jason Maratos |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Boca Raton, FL : , : Routledge, an imprint of Taylor and Francis, , [2018] |
|
©2015 |
|
|
|
|
|
|
|
|
|
ISBN |
|
0-429-91390-7 |
9780429896950 |
0-429-89967-X |
0-429-47490-3 |
1-78241-221-2 |
|
|
|
|
|
|
|
|
Edizione |
[1st ed.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (337 p.) |
|
|
|
|
|
|
Collana |
|
New International Library of Group Analysis |
|
|
|
|
|
|
Altri autori (Persone) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di contenuto |
|
part PART I: HISTORICAL FOUNDATIONS -- chapter 1 Principles and practice of group therapy / S. H. Foulkes -- chapter 2 Introduction to group-analytic psychotherapy / S. H. Foulkes -- chapter 3 The group as matrix of the individual’s mental life / S. H. Foulkes -- chapter 4 General introduction: the individual as a whole in a total situation / S. H. Foulkes -- chapter 5 Book review: The Civilising Process. Vol. 1—The History of Manners, by Norbert Elias / S. H. Fuchs -- part PART II: GROUP-ANALYTIC THEORY -- chapter 6 My philosophy in psychotherapy / S. H. Foulkes -- chapter 7 Group-analysis: taking the non-problem seriously / Caroline Garland -- chapter 8 Destructive phases in groups / Jeff Roberts -- part PART III: PSYCHO-ANALYSIS AND GROUP-ANALYSIS -- chapter 9 Psycho-analysis and group analysis / Malcolm Pines -- chapter 10 Some reflections on Bion’s basic assumptions from a group-analytic viewpoint / Dennis Brown -- chapter 11 The theory of Incohesion: Aggregation/Massification as the fourth basic assumption in the unconscious life of groups and group-like social systems -- chapter 12 “Holding” and “containing” in the group and society / Colin James -- part PART IV: GROUP-ANALYSIS |
|
|
|
|
|
|
|
|
|
|
|
AND SOCIETY -- chapter 13 Group analysis: the problem of context / Earl Hopper -- chapter 4 TEEN The language of the group: monologue, dialogue and discourse in group analysis / John Schlapobersky -- chapter 15 The psyche and the social world / Dennis Brown -- part PART V: CHALLENGES TO THE THEORY/EXTENSIONS -- chapter 6 TEEN The anti-group: destructive forces in the group and their therapeutic potential / Morris Nitsun -- chapter 17 Specialists without spirit, sensualists without heart: psychotherapy as a moral endeavour / Farhad Dalal -- chapter 18 Complexity and the group matrix / Ralph Stacey. |
|
|
|
|
|
|
Sommario/riassunto |
|
The Institute of Group Analysis (IGA) celebrates forty years from its foundation with the publication of two new volumes tracing the foundations and applications of Group Analysis. The first volume ('Foundations') aims to publicise the foundations of group analysis (with the earliest papers of Foulkes) as well as the most influential theoretical contributions by pillars of modern group analysis, such as Pines, Brown, and Hopper. The reader will be able to see the development of Group Analysis, form an opinion about the trajectory that it follows, and judge which way the tradition of openness and creative integration of diverse theoretical contributions will lead in the twenty-first century. The second volume ('Applications') focuses on the numerous fields of work that use group analytic principles. Workers in the field of forensic psychotherapy would now consider it a great omission if they did not use some form of group analytic intervention, as would professionals dealing with those who manifest personality disorders, or those who work with different age groups, such as adolescents. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3. |
Record Nr. |
UNINA9911027075903321 |
|
|
Autore |
Garden Oliver A |
|
|
Titolo |
Veterinary Clinical Immunology |
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Newark : , : John Wiley & Sons, Incorporated, , 2025 |
|
©2026 |
|
|
|
|
|
|
|
|
|
ISBN |
|
1-119-23295-3 |
1-119-23286-4 |
|
|
|
|
|
|
|
|
Edizione |
[1st ed.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (653 pages) |
|
|
|
|
|
|
Altri autori (Persone) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Nota di contenuto |
|
Cover -- Title Page -- Copyright Page -- Contents -- List of Contributors -- Preface -- About the Companion Website -- Section 1 A Primer for the Clinician -- Chapter 1 A Clinician's Guide to the Immune System: Innate and Adaptive Immunity -- 1.1 Introduction:Innate Versus Adaptive Immunity -- 1.2 The Innate Response - An Immediate Front Line of Defense -- 1.2.1 Physical Barriers and Cells -- 1.2.2 Pathogen Recognition and Discrimination -- 1.2.3 Cellular Communication -- 1.2.4 The Complement System -- 1.3 TheAdaptive Response -Specialized Cells with Specificity and Memory -- 1.3.1 Generation of Diversity: Antigen Receptors -- 1.3.2 Antigen-Presenting Cells -- 1.3.3 T Cells -- 1.3.3.1 Origins and Importance -- 1.3.3.2 Phenotypic Diversity -- 1.3.4 B Cells -- 1.4 Blurringthe Lines Between Innate and Adaptive Immunity -- 1.5 Regulationof the Immune Response -- 1.6 CellDeath Mechanisms -- 1.7 Microbiotaand Immunity -- 1.8 Areas for Further Research -- Companion Website -- Key References -- Chapter 2 Pathophysiology of Immune-Mediated Disease -- 2.1 Introduction -- 2.2 A Brief History of Tolerance -- 2.3 Immune Tolerance in Clinical Medicine -- 2.3.1 Selection of T and B Cells -- 2.3.2 Regulatory T Cells -- 2.3.3 Regulation of Lymphocyte Activation -- 2.3.4 Innate Immune Tolerance -- 2.3.5 Regulation by Cytokines -- 2.3.6 Heterogeneity in Immune Tolerance -- 2.4 Clinical Spectrum of Immune-Mediated Diseases -- 2.4.1 Autoimmune Diseases -- 2.4.2 |
|
|
|
|
|
|
|
|
|
Autoinflammatory Diseases -- 2.4.3 Allergy and Anaphylaxis -- 2.5 Risk Factors for Autoimmune Disease -- 2.5.1 Genetic Predisposition -- 2.5.2 Epigenetic Landscape -- 2.5.3 Immune Tolerance and the Microbiome -- 2.5.4 Molecular Mimicry -- 2.5.5 Superantigens -- 2.6 Areas for Further Research -- Companion Website -- Key References -- Chapter 3 Immunogenetics: The Final Frontier -- 3.1 Introduction. |
3.2 Types of Genetic Variation -- 3.2.1 Single Nucleotide Polymorphisms (SNPs) -- 3.2.2 Indels (Insertions and/or Deletions) -- 3.2.3 Copy Number Variants (CNVs) -- 3.2.4 Inversions and Chromosomal Rearrangements -- 3.3 Investigating Genetic Variation -- 3.3.1 Candidate Gene Study -- 3.3.2 Linkage Analysis -- 3.3.3 Genome-Wide Association Study (GWAS) -- 3.3.4 Next-Generation Sequencing Technology -- 3.4 Challenges in Understanding Genetic Risk in Complex Diseases -- 3.4.1 Complexity of Genetic Predisposition -- 3.4.2 The Role of the Environment -- 3.4.3 Phenocopies of Disease -- 3.4.4 Age-Matched, Healthy Control Samples for Case-Control Studies -- 3.4.5 Population Structure -- 3.4.6 The Concept of "Fixed Disease Risk" Within Certain Breeds or Populations -- 3.4.7 Knowledge of Normal Variation in the Canine and Feline Genome -- 3.4.8 Epigenetic Influences -- 3.4.9 Genes of the Major Histocompatibility Complex -- 3.5 The Canine MHC -- 3.6 The Feline MHC -- 3.7 Non-MHC Regions -- 3.7.1 Genetic Polymorphism in Cytokines, Chemokines, and Their Receptors -- 3.7.2 Transporters Associated with Antigen Processing -- 3.8 Clinical Examples of Genetic Influences -- 3.8.1 Immune-Mediated and Autoimmune Diseases -- 3.8.2 Onco-Immunology -- 3.8.3 Immunodeficiency -- 3.8.4 Innate Immune Responses to Pathogens -- 3.8.5 Infectious Disease Susceptibility -- 3.8.6 Vaccination Responses -- 3.8.7 Transplantation -- 3.9 Areas for Further Research -- Companion Website -- Key References -- Chapter 4 Vector-Borne Pathogens and Immune-Mediated Disease -- 4.1 Introduction -- 4.2 Mechanisms of Infection and Loss of Immune Tolerance -- 4.3 Vector-Borne Organisms as a Cause of Immune-Mediated Disease? -- 4.3.1 Overview -- 4.3.2 Immune-Mediated Hemolytic Anemia -- 4.3.2.1 Pathophysiology -- 4.3.2.2 Babesia species -- 4.3.2.3 Hemotropic Mycoplasma -- 4.3.2.4 Bartonella species. |
4.3.2.5 Anaplasma species -- 4.3.2.6 Ehrlichia species -- 4.3.2.7 Other organisms -- 4.3.3 Immune Thrombocytopenia -- 4.3.3.1 Pathophysiology -- 4.3.3.2 Vector-borne Organisms -- 4.3.4 Immune-Mediated Polyarthritis -- 4.3.4.1 Classification -- 4.3.4.2 Pathophysiology -- 4.3.4.3 Leishmania species -- 4.3.4.4 Borrelia burgdorferi -- 4.3.4.5 Anaplasma phagocytophilum -- 4.3.4.6 Ehrlichia species -- 4.3.4.7 Bartonella species -- 4.3.4.8 Rickettsia rickettsii -- 4.3.4.9 Dirofilaria immitis -- 4.3.5 Protein-Losing Nephropathy (PLN) -- 4.3.5.1 Pathophysiology -- 4.3.5.2 Leishmania species -- 4.3.5.3 Dirofilaria immitis -- 4.3.5.4 Piroplasms -- 4.3.5.5 Ehrlichia canis -- 4.3.5.6 Borrelia burgdorferi -- 4.3.5.7 Anaplasma phagocytophilum -- 4.3.5.8 Bartonella species -- 4.4 Screening for Vector-Borne Pathogens -- 4.5 Consequences of Immunosuppression in Patients with Occult Vector-Borne Infections -- 4.6 Areas for Further Research -- Companion Website -- Key References -- Section 2 Diagnostic Approaches and Treatment -- Chapter 5 Diagnosing Immune-Mediated Disease: General Approach and Specific Tests -- 5.1 Introduction: General Approach -- 5.1.1 Clinical Reasoning -- 5.1.1.1 Introduction: Diagnostic Error and Clinical Reasoning -- 5.1.1.2 Types of Clinical Reasoning: Non-Analytical and Analytical -- 5.1.1.3 Problem-OrientedClinical Reasoning as an Analytical Reasoning Tool -- 5.1.1.4 Generating the Initial Problem List and Associated Differential |
|
|
|
|
|
|
|
Diagnoses -- 5.2 Specific Diagnostic Tests for Immune-Mediated Disease -- 5.2.1 General Concepts -- 5.2.2 Enzyme-Linked Immunosorbent Assays -- 5.2.3 Radioimmunoassays -- 5.2.4 Immunohistochemistry, Immunocytochemistry, and Immunofluorescent Assays -- 5.2.5 Flow Cytometry -- 5.2.6 Agglutination Assays -- 5.3 Specific Tests for Common Immune-Mediated Diseases -- 5.3.1 Immune-Mediated Hemolytic Anemia -- 5.3.1.1 Anemia. |
5.3.1.2 Hemolysis -- 5.3.1.3 Anti-ErythrocyteAntibodies -- 5.3.2 Immune-Mediated Polyarthropathy (IMPA) -- 5.3.2.1 Synovial Fluid Cytology -- 5.3.2.2 Detection of Immunoglobulins -- 5.3.3 Immune Thrombocytopenia -- 5.3.4 Autoimmune Diseases Affecting the Neuromuscular System -- 5.3.4.1 Myasthenia Gravis -- 5.3.4.2 Masticatory Muscle Myositis (MMM) -- 5.3.5 Autoimmune Disease Affecting Multiple Organ Systems -- 5.3.6 Immune-Mediated Glomerulonephritis -- 5.3.7 Cutaneous Autoimmune Disease -- 5.3.8 Idiopathic Inflammatory Bowel Disease (IBD) -- 5.4 Areas for Further Research -- Companion Website -- Key References -- Chapter 6 Treating Immune-Mediated Disease: What to Use and When -- 6.1 Introduction -- 6.2 Systemic Immunosuppressive Therapy -- 6.2.1 Glucocorticoids -- 6.2.2 Cyclosporine -- 6.2.3 Mycophenolate Mofetil -- 6.2.4 Azathioprine -- 6.2.5 Leflunomide -- 6.2.6 Monitoring Response to Therapy -- 6.3 Targeted Organ Immunosuppression -- 6.3.1 Budesonide and Fluticasone -- 6.4 Immune-Mediated Blood Disorders: Other Treatment Considerations -- 6.4.1 Gastroprotectants -- 6.4.2 Human Intravenous Immunoglobulin (hIVIG) -- 6.4.3 Splenectomy -- 6.4.4 Therapeutic Plasma Exchange -- 6.4.5 Vincristine -- 6.5 Miscellaneous Anti-Inflammatory and Immunosuppressive Agents -- 6.6 Areas for Further Research -- Companion Website -- Key References -- Section 3 Specific Immune-Mediated Diseases -- Chapter 7 Blood and Hematopoietic System -- 7.1 Introduction -- 7.2 Pathobiology and Etiology -- 7.2.1 Immune-Mediated Hemolytic Anemia -- 7.2.2 Immune Thrombocytopenia -- 7.2.3 Immune-Mediated Neutropenia -- 7.3 Making a Diagnosis -- 7.3.1 Immune-Mediated Hemolytic Anemia -- 7.3.2 Immune Thrombocytopenia -- 7.3.3 Immune-Mediated Neutropenia -- 7.4 Immune-Mediated Blood Disorders: General Treatment Considerations -- 7.5 Areas for Further Research -- Companion Website. |
Key References -- Chapter 8 Musculoskeletal System -- 8.1 Introduction -- 8.2 Pathobiology and Etiology -- 8.2.1 Immune-Mediated Polyarthritis -- 8.2.2 Polymyositis -- 8.2.3 Masticatory Muscle Myositis -- 8.3 Immune-Mediated Polyarthritis -- 8.3.1 Clinical Summary -- 8.3.1.1 Making a Diagnosis -- 8.3.1.2 Clinical Presentation -- 8.3.1.3 Classification -- 8.3.2 Treatment Options -- 8.3.2.1 MedicalTreatment -- 8.3.2.2 SurgicalTreatment -- 8.3.2.3 Monitoring for Treatment -- 8.3.3 Prognosis -- 8.4 Polymyositis -- 8.4.1 Clinical Summary -- 8.4.1.1 Making a Diagnosis -- 8.4.1.2 Clinical Presentation -- 8.4.2 Treatment Options -- 8.4.3 Prognosis -- 8.5 Masticatory Muscle Myositis -- 8.5.1 Clinical Summary -- 8.5.1.1 Making a Diagnosis -- 8.5.1.2 Clinical Presentation -- 8.5.2 Treatment Options -- 8.5.3 Prognosis -- 8.6 Areas for Further Research -- Companion Website -- Key References -- Chapter 9 Central and Peripheral Nervous System -- 9.1 Introduction -- 9.1.1 Pathobiology of the Nervous and Immune Systems -- 9.1.1.1 Relationships Between the Central Nervous and Immune Systems -- 9.1.1.2 Immune Surveillance During Homeostasis -- 9.1.1.3 Innate and Adaptive Immune Responses -- 9.1.1.4 Loss of Tolerance -- 9.1.1.5 The Concept of Neuroinflammation -- 9.1.1.6 The Immune System and Peripheral Nerves -- 9.1.2 Making a Diagnosis of Immune-Mediated |
|
|
|
|
|
|
|
|
|
Neurologic Disease -- 9.2 Specific Immune-Mediated Diseases of the Central Nervous System -- 9.2.1 Meningoencephalomyelitis in Dogs -- 9.2.1.1 Meningoencephalomyelitis of Unknown Origin -- 9.2.1.2 Granulomatous Meningoencephalitis, Necrotizing Meningoencephalitis and Necrotizing Leukoencephalitis -- Clinical Summary -- 9.2.1.3 Eosinophilic Meningoencephalitis -- 9.2.1.4 Meningoencephalitis in Greyhounds -- 9.2.1.5 Idiopathic Generalized Tremor Syndrome -- 9.2.2 Steroid-Responsive Meningitis-Arteritis. |
9.2.3 Immune-Mediated Meningoencephalitis in Cats. |
|
|
|
|
|
|
Sommario/riassunto |
|
A richly illustrated reference on immune-mediated diseases in dogs and cats, grounded in veterinary clinical practice Veterinary Clinical Immunology provides clear and accurate information on the pathogenesis, diagnosis, and treatment of immune-mediated diseases in small animals. |
|
|
|
|
|
|
|
| |